Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production.

[1]  K. Krause,et al.  The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. , 1985, Journal of immunology.

[2]  J. Adams,et al.  1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. , 1985, Journal of immunology.

[3]  W. Fiers,et al.  Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. , 1985, Journal of immunology.

[4]  C. Dinarello,et al.  Chemical characterization of an interleukin-1-inducing substance derived from human mixed leukocyte reactions: IL-1-inducing substance is not gamma interferon. , 1985, The Yale journal of biology and medicine.

[5]  S. Krane,et al.  Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons. , 1985, Journal of Immunology.

[6]  L. Glimcher,et al.  1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. , 1984, Journal of immunology.

[7]  M. Fanger,et al.  Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). , 1984, The Journal of clinical investigation.

[8]  S. Manolagas,et al.  1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. , 1984, Science.

[9]  D. Katz.  Immunosuppression as a physiological homeostatic mechanism. , 1984, Immunology today.

[10]  S. Krane,et al.  1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. , 1984, The Journal of clinical investigation.

[11]  I. Gery,et al.  Production of intra- and extracellular interleukin-1 (IL-1) by human monocytes. , 1984, Clinical immunology and immunopathology.

[12]  S. Krane,et al.  Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. , 1983, The Journal of clinical endocrinology and metabolism.

[13]  R. Russell,et al.  An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.

[14]  J. Adams,et al.  Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. , 1983, The Journal of clinical investigation.

[15]  S. Manolagas,et al.  1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.

[16]  S. Krane,et al.  Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes. , 1983, Journal of immunology.

[17]  F. Bettens,et al.  Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. , 1983, Journal of immunology.

[18]  L. Orci,et al.  The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). , 1982, Endocrine reviews.

[19]  A. Munck,et al.  Prostaglandin inhibition of T-cell proliferation is mediated at two levels. , 1981, Cellular immunology.

[20]  D. Feldman,et al.  1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. , 1981, Endocrinology.

[21]  D. Bainton,et al.  Identification of alpha-naphthyl butyrate esterase as a plasma membrane ectoenzyme of monocytes and as a discrete intracellular membrane- bounded organelle in lymphocytes , 1981, The Journal of experimental medicine.

[22]  M. Favata,et al.  The functional relationship of the interleukins , 1980, The Journal of experimental medicine.

[23]  F. Ross,et al.  Characterization of the 1 alpha,25-dihydroxyvitamin D3 receptor from rat intestinal cytosol. , 1979, The Journal of biological chemistry.

[24]  G. Crabtree,et al.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. , 1979, Journal of immunology.

[25]  D. Feldman,et al.  A receptor-like binding macromolecule for 1 alpha, 25-dihydroxycholecalciferol in cultured mouse bone cells. , 1979, The Journal of biological chemistry.

[26]  A. Norman,et al.  Studies on the mode of action of calciferol. XVIII. Evidence for a specific high affinity binding protein for 1,25 dihydroxyvitamin D3 in chick kidney and pancreas. , 1979, Biochemical and biophysical research communications.

[27]  R. Williams,et al.  High-affinity binding sites for prostaglandin E on human lymphocytes. , 1979, Cellular immunology.

[28]  M. Haussler,et al.  Basic and clinical concepts related to vitamin D metabolism and action (second of two parts). , 1977, The New England journal of medicine.

[29]  G. Crabtree,et al.  Glucocorticoid receptors and glucocorticoid sensitivity of mitogen stimulated and unstimulated human lymphocytes , 1977, Nature.

[30]  S. Krane,et al.  Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells , 1977, The Journal of experimental medicine.

[31]  H. Besedovsky,et al.  Network of immune-neuroendocrine interactions. , 1977, Clinical and experimental immunology.

[32]  D. Robinson,et al.  Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. , 1975, The Journal of clinical investigation.

[33]  L. Levine,et al.  Specificities of Prostaglandins B1, F1α, and F2α Antigen-Antibody Reactions , 1971 .

[34]  H. DeLuca,et al.  Bone mineral mobilization activity of 1,25-dihydroxycholecalciferol, a metabolite of vitamin D. , 1971, Archives of biochemistry and biophysics.